Get the full Hello Haven company profile
Access contacts, investors, buying signals & more
Hello Haven, a startup developing a "second brain" for users, has secured $15.0M in a pre-seed funding round. The company aims to offload mental clutter by learning individual goals and routines, promising to filter noise and manage everyday tasks.
Its platform is designed to be always on and always learning, giving users back their time, clarity, and confidence. Hello Haven positions itself as a system built for real life, handling what matters most so users don't have to carry it all.
Hello Haven Raises $15M in Pre-Seed Funding - FinSMEs Before you continue EN English United States Deutsch English Español Français Italiano All languages Afrikaans azərbaycan bosanski català Čeština Cymraeg Dansk Deutsch eesti English United Kingdom Español España Español Latinoamérica euskara Filipino Français Canada Français France Gaeilge galego Hrvatski Indonesia isiZulu íslenska Italiano Kiswahili latviešu lietuvių magyar Melayu Nederlands norsk o‘zbek polski Português Brasil Português Portugal română shqip Slovenčina slovenščina srpski (latinica) Suomi Svenska Tiếng Việt Türkçe Ελληνικά беларуская български кыргызча қазақ тілі македонски монгол Русский српски Українська ქართული հայերեն עברית اردو العربية فارسی አማርኛ नेपाली मराठी हिन्दी অসমীয়া বাংলা ਪੰਜਾਬੀ ગુજરાતી ଓଡ଼ିଆ தமிழ் తెలుగు ಕನ್ನಡ മലയാളം සිංහල ไทย ລາວ မြန်မာ ខ្មែរ 한국어 日本語 简体中文 繁體中文 繁體中文 香港 Sign in EN English United States Deutsch English Español Français Italiano All languages Afrikaans azərbaycan bosanski català Čeština Cymraeg Dansk Deutsch eesti English United Kingdom Español España Español Latinoamérica euskara Filipino Français Canada Français France Gaeilge galego Hrvatski Indonesia isiZulu íslenska Italiano Kiswahili latviešu lietuvių magyar Melayu Nederlands norsk o‘zbek polski Português Brasil Português Portugal română shqip Slovenčina slovenščina srpski (latinica) Suomi Svenska Tiếng Việt Türkçe Ελληνικά беларуская български кыргызча қазақ тілі македонски монгол Русский српски Українська ქართული հայերեն עברית اردو العربية فارسی አማርኛ नेपाली मराठी हिन्दी অসমীয়া বাংলা ਪੰਜਾਬੀ ગુજરાતી ଓଡ଼ିଆ தமிழ் తెలుగు ಕನ್ನಡ മലയാളം සිංහල ไทย ລາວ မြန်မာ ខ្មែរ 한국어 日本語 简体中文 繁體中文 繁體中文 香港 Sign in Before you continue to Google We use cookies and data, including IP addresses, to Deliver and maintain Google services Track outages and protect against spam, fraud, and abuse Measure audience engagement and site statistics to understand how our services are used and enhance the quality of those services If you choose to “Accept all,” we will also use cookies and data, including IP addresses, to Develop and improve new services Deliver and measure the effectiveness of ads Show personalized content, depending on your settings Show personalized ads, depending on your settings If you choose to “Reject all,” we will not use cookies or IP addresses for these additional purposes.
Comp AI
No matter your stage, Comp AI helps you automate compliance, collect evidence, and prove trust continuously - all from a single, AI-powered platform. We make SOC 2, ISO 27001, HIPAA and GDPR feel effortless. Our AI agents handle most of the work - from evidence collection and monitoring to policy management and audit prep - so your team can focus on building.
$34.0M Series a
today
Circle Pharma, Inc.
Circle Pharma initiated operations in June 2014 with seed funding from Pfizer, Inc. and Mission Bay Capital, LLP; we received additional seed funding from ShangPharma Investment Group Limited in November 2015. We recently raised Series B and Series C financing from The Column Group and NextTech Invest. We design and develop bioavailable macrocyclic peptide therapeutics against important clinical targets. We do this by applying a computational structure-based design approach that combines physics (conformational modeling), chemistry (innovative molecular components) and biology (protein target structure and function). We have selected intracellular protein-protein interactions that play key roles in cancer as the initial target group for our internal pipeline development. Circle is taking a new approach to the development of macrocylic peptide therapeutics that is based on the pioneering work of its founders to understand and computationally predict drug-like properties of macrocycles. Circle is advancing this understanding to design novel, inherently permeable macrocyclic peptide drug candidates against Circle’s internal targets and those of our collaboration partners. Our workflow includes the use of proprietary algorithms to design large, conformationally diverse, virtual libraries of cell permeable macrocyclic scaffolds that incorporate natural and non-natural backbone components. We deploy these virtual scaffold libraries in subsequent design steps that include the incorporation of functional side chains selected for both target binding and maintenance of permeability. Candidate compounds are synthesized and tested for both permeability and target affinity and the results are used to inform subsequent design cycles.
Largest funding rounds in AI on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Nuance Healthcare United States | Unknown | $19.7B | 2y ago |
| 2 |  OpenAI United States | Unknown | $13.0B |
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | .png&w=3840&q=75) Biochar Industrial Group (BIG) | Pre-seed | $1.5M | today |
| 2 |  henneth.ai United Kingdom | Pre-seed | $1.0M | today |
Non-personalized content is influenced by things like the content you’re currently viewing, activity in your active Search session, and your location. Non-personalized ads are influenced by the content you’re currently viewing and your general location. Personalized content and ads can also include more relevant results, recommendations, and tailored ads based on past activity from this browser, l
$92.5M Series e
today
| 2y ago |
| 3 |  Anthropic United States | Series f | $13.0B | 1y ago |
| 4 |  AIMAX United Kingdom | Unknown | $10.0B | 2y ago |
| 5 |  Preferred Networks, Inc. Japan | Unknown | ¥10.0B | 1y ago |
| 3 |
 AcouBatt United Kingdom |
| Pre-seed |
| $1.5M |
| today |
| 4 |  Sylvia Health Denmark | Pre-seed | $647.8K | 1d ago |
| 5 |  Iusful | Pre-seed | $2.0M | 1d ago |
Trusted by 200+ sales teams
See who invested in Hello Haven and reach their contacts directly.
Start free trial
OCTA
Recently received
Laki Power
Recently received
Health Force
Recently received
